<DOC>
	<DOCNO>NCT00487188</DOCNO>
	<brief_summary>To assess efficacy enfuvirtide ( Fuzeon ) add HAART compare treatment HAART alone achieve maintain viral load suppression .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy Adding Enfuvirtide Oral Highly Active Antiretroviral Therapy ( HAART ) Human Immunodeficiency Virus ( HIV ) Patients With Prior Treatment Experience</brief_title>
	<detailed_description>This study consist two phase . In Induction phase patient randomize Baseline 1 ( BL1 ) 1:2 ratio receive : - I1 : HAART - I2 : Enfuvirtide ( 90 mg twice day ) + HAART . Participants achieve viral suppression &lt; 50 copies/mL week 24 , confirm week 28 early , qualified enter Maintenance Phase start Baseline 2 ( BL2 ) , four week confirmation response . The Maintenance Phase consist three treatment group : - M1 : HAART continue ( patient I1 ) Patients ENF+HAART ( I2 ) re-randomized ( 1:1 ratio ) BL2 : - M2 : Enfuvirtide stop HAART continue - M3 : Enfuvirtide + HAART continue . The duration Maintenance Phase BL2 48 week BL1 . BL2 could start early Week 12 late Week 32 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>HIV1 infect adult &gt; =18 year age ; currently antiretroviral ( ARV ) therapy ; previously treat 2 3 different antiretroviral class ; HIV1 Ribonucleic acid ( RNA ) &gt; =1,000 copies/mL ; Cluster differentiation antigen four ( CD4 ) lymphocyte count &gt; =200 cells/mm^3 ; female childbearing potential must willing use reliable form effective barrier contraception duration study 30 day last dose study drug . history prior use enfuvirtide T1249 ; woman pregnant , breastfeed plan become pregnant study ; active , untreated opportunistic infection ; patient treatment interruption , patient interrupt ARV therapy within 4 week screen screen period reason either toxicity management .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>